HEREDITY is a prestigious academic journal published by SpringerNature, specializing in the dynamic fields of Genetics and Genetics (Clinical). With a history of excellence since its inception in 1947, this journal has established itself as a significant contributor to the understanding of genetic research, addressing both foundational principles and clinical applications. Operating without an open access model, it maintains a strong reputation with an impact factor that reflects its rigorous peer-review process and high-quality submissions, ranking in the top quartiles of its category as evidenced by its Q2 classification in Genetics and Genetics (clinical) for 2023. Further, HEREDITY holds commendable positions in Scopus rankings, illustrating its influence within the field, currently placed #21 out of 99 in Medicine (Clinical Genetics) and #87 out of 347 in Biochemistry, Genetics, and Molecular Biology (Genetics). Researchers, professionals, and students are invited to explore the latest discoveries and advancements in genetics through this esteemed journal, contributing to the broader discourse and innovation within the field.

Nature Genetics is a premier journal in the field of genetics published by NATURE PORTFOLIO, renowned for its impactful research and significant contributions to the understanding of genetic mechanisms and their implications for human health. Since its establishment in 1992, the journal has continually maintained a strong reputation, evidenced by its impressive Q1 ranking in the Genetics category and a commendable Scopus ranking of #4 out of 347 in Genetics, placing it in the 98th percentile. Although it does not currently offer Open Access options, Nature Genetics remains a critical resource for researchers and practitioners, providing cutting-edge studies and papers that drive advancements in both fundamental and applied genetic research. With a global readership and contributions from leading scientists around the world, this journal is a vital platform for disseminating innovative findings and fostering discussions at the frontier of genetics.

Human Genomics, published by BMC, is a leading open-access journal dedicated to advancing the field of genomics and its applications in health and disease. Since its inception in 2003, the journal has provided a vital platform for researchers to disseminate groundbreaking findings related to genetic research, contributing significantly to areas such as Drug Discovery, Genetics, Molecular Biology, and Molecular Medicine, as reflected in its Q1 and Q2 quartile rankings throughout 2023. With an ISSN of 1473-9542 and an E-ISSN of 1479-7364, Human Genomics not only delivers high-quality, peer-reviewed research but also ensures accessibility to a broader audience, empowering professionals, students, and academics to stay at the forefront of genomic science. Through its rigorous editorial standards and impactful publications, the journal fosters a collaborative environment for innovative research across the globe from its base in the United Kingdom. By promoting open access since its launch, Human Genomics continues to enhance the visibility and impact of genetic studies, making it an essential resource for anyone involved in the rapidly evolving field of human genomics.

Genetic Testing and Molecular Biomarkers, an esteemed journal published by MARY ANN LIEBERT, INC, serves as a pivotal platform for advancing the field of genetic research and its applications in medicine. Focused on the innovative intersections of genetics and biomarker discovery, this journal has consistently contributed meaningful insights since its inception in 2009, with its scope evolving through 2024. With an ISSN of 1945-0265 and an E-ISSN of 1945-0257, it offers both traditional and open access options to cater to a broad audience of researchers, professionals, and students. Despite its current classification in the Q4 and Q3 quartiles for Genetics (clinical) and Medicine (miscellaneous) respectively, the journal remains committed to publishing high-quality, peer-reviewed articles that push the boundaries of knowledge in the field. As the landscape of genomic medicine continues to expand, Genetic Testing and Molecular Biomarkers is positioned as a crucial resource for disseminating cutting-edge discoveries and fostering interdisciplinary collaboration.

Annual Review of Genomics and Human Genetics, published by ANNUAL REVIEWS, represents a pivotal platform in the field of Genetics and Molecular Biology. With an impressive impact factor reflecting its high citation rate and scholarly influence, this journal is renowned for its authoritative reviews that synthesize current research across genomics and human genetics. Highlighting its Q1 category rankings in both Genetics and Clinical Genetics, as well as its ranking within the top tiers of Biochemistry and Genetics, the journal stands out as a leading resource for researchers, professionals, and students eager to stay abreast of groundbreaking developments in these rapidly evolving fields. While not currently an open access journal, its rigorous peer-review process ensures the highest standards of scientific integrity. Researchers can access comprehensive reviews that delve into both fundamental genetics concepts and cutting-edge discoveries, making it an essential resource for advancing understanding in human genetics and its applications.

BEHAVIOR GENETICS is a leading peer-reviewed journal published by Springer, dedicated to advancing the field of behavioral genetics through the dissemination of original research and comprehensive reviews. With its foundation dating back to 1970, the journal has established itself as a crucial forum for scientists studying the interplay between genetic factors and behavior, addressing a diverse range of topics from animal behavior to human psychology. Currently, BEHAVIOR GENETICS holds prestigious rankings with a Q1 quartile in Ecology, Evolution, Behavior and Systematics, and Q2 rankings in both Genetics and Clinical Genetics, as of 2023. This positions the journal among the top tier of scholarly publications, with significant impact reflected in its Scopus ranking across various categories. Researchers, professionals, and students can explore valuable insights and opportunities for collaboration in this vibrant field, although it is noteworthy that the journal offers standard access options. As a valuable resource for cutting-edge discoveries, BEHAVIOR GENETICS continues to foster a deeper understanding of the genetic influences on behavior, making it essential reading for anyone invested in behavioral research.

Human Genetics and Genomics Advances is a premier academic journal published by Elsevier, dedicated to the field of human genetics and genomic medicine. With an ISSN of 2666-2477, this journal has quickly established itself as a leading platform for disseminating cutting-edge research from its inception in 2020. Featured prominently in Q1 categories for both Clinical Genetics and Molecular Medicine as of 2023, it ranks favorably among its peers, reflected in its Scopus rankings. The journal not only offers valuable insights into the latest advancements and applications in genetics but also facilitates open dialogue among researchers, clinicians, and students. As an open access publication, it ensures that groundbreaking findings in genetics are readily accessible to a global audience, promoting knowledge sharing and collaboration. Human Genetics and Genomics Advances continues to be instrumental in moving the field forward, providing a vital resource for those at the forefront of genetic and genomic research.

GENETICS SELECTION EVOLUTION is a prominent open-access journal published by BMC since 1989, situated in the United Kingdom. With a focus on evolutionary genetics and the mechanisms of selection, this journal serves as a pivotal platform for researchers, professionals, and students in the fields of Animal Science, Ecology, and Genetics. Notably, it has achieved remarkable rankings, being categorized in Q1 for various disciplines, reflecting its high impact and contribution to scientific discourse. The journal boasts an impressive recognition in the Scopus rankings, sitting at the 94th percentile in Animal Science and Zoology, and 86th percentile in Ecology and Evolution, underscoring its influence in these domains. Offering open access since its inception, it ensures broad dissemination of knowledge, allowing critical research findings to reach a wider audience. As we converge into its upcoming issues, the journal continues to foster the exploration of innovative genetic research and selection processes, shaping the future of evolutionary studies.

PSYCHIATRIC GENETICS, published by LIPPINCOTT WILLIAMS & WILKINS, is a pivotal journal dedicated to the interdisciplinary study of genetic factors in psychiatric disorders, bridging the fields of genetics, psychiatry, and neuroscience. With a commitment to advancing research from its inception in 1990 and continuing through 2024, the journal provides a platform for innovative studies and findings that explore the genetic underpinnings of mental health. Although not currently an Open Access publication, it reaches a wide audience concerned with the complex interplay between genetics and psychiatric conditions, contributing to its Q3 and Q2 quartile rankings across multiple relevant categories in 2023. The importance of this journal cannot be understated; it serves as a crucial resource for researchers, clinicians, and students eager to uncover insights that could lead to more effective interventions and treatments in the realm of mental health.

Welcome to the Journal of Human Genetics, a premier publication in the field of human genetics, published by SpringerNature. With a commitment to sharing groundbreaking research, this journal has been at the forefront of genetic studies since its establishment in 1961, converging its focus in 1996 and continuing to evolve through 2024. It holds a respected Q2 ranking in both the Genetics and Clinical Genetics categories, reflecting its significant contribution to the scientific community. With a notable Scopus ranking of 23rd out of 99 in Clinical Genetics and 95th out of 347 in Genetics, the journal offers a platform for high-impact research that informs clinical practices and advances the understanding of genetic disorders. Operating under an open-access model, it ensures that findings are readily accessible to researchers, professionals, and students worldwide. Join us in exploring the complexities of human genetics and contribute to the ongoing discourse in this dynamic field.